Does the Framingham cardiovascular disease risk score also have predictive utility for dementia death? An individual participant meta-analysis of 11,887 men and women



      Individual cardiovascular disease (CVD) risk factors are associated with dementia. For the first time, we investigated whether the Framingham CVD risk score–which comprises these multiple risk factors–was also associated with future dementia risk.


      Individual participant meta-analysis of two large, general population cohort studies (N = 11,887). For the purposes of comparison of the dementia results, we also examined the association between the Framingham CVD risk score and CVD-related death.


      Framingham CVD risk score was associated with dementia death (hazard ratio per 10% increased risk, 95% confidence interval: 4.00, 2.44–6.56). Adjusting for age eliminated this association (1.04, 0.53–2.01); similarly, age explained 88% of the ability of the Framingham CVD risk score to predict CVD death.


      The Framingham CVD risk score was no more strongly associated with future dementia than age. It therefore offers no added value in predicting dementia.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Stephan B.C.M.
        • Brayne C.
        Vascular factors and prevention of dementia.
        Int Rev Psychiatry. 2008; 20: 344-356
        • Pendlebury S.T.
        • Rothwell P.M.
        Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis.
        Lancet Neurol. 2009; 8: 1006-1018
        • D'Agostino R.B.
        • Vasan R.S.
        • Pencina M.J.
        • et al.
        General cardiovascular risk profile for use in primary care.
        Circulation. 2008; 117: 743-753
        • Kaffashian S.
        • Dugravot A.
        • Nabi H.
        • et al.
        Predictive utility of the Framingham general cardiovascular disease risk profile for cognitive function: evidence from the Whitehall II Study.
        Eur Heart J. 2011; 32: 2326-2332
        • Wolf P.A.
        Contributions of the Framingham Heart Study to stroke and dementia epidemiologic research at 60 years.
        Arch Neurol. 2012; 69: 567-571
        • Mindell J.
        • Biddulph J.P.
        • Hirani V.
        • et al.
        Cohort profile: the health survey for England.
        Int J Epidemiol. 2012; 41: 1585-1593
        • Russ T.C.
        • Stamatakis E.
        • Hamer M.
        • Starr J.M.
        • Kivimaki M.
        • Batty G.D.
        Association between psychological distress and mortality: individual participant pooled analysis of 10 prospective cohort studies.
        Brit Med J. 2012; 345: e4933
        • Kim H.C.
        • Greenland P.
        • Rossouw J.E.
        • et al.
        Multimarker prediction of coronary heart disease risk: the Women's Health Initiative.
        J Am Coll Cardiol. 2010; 55: 2080-2091
        • Russ T.C.
        • Batty G.D.
        • Starr J.M.
        Cognitive and behavioural predictors of survival in Alzheimer disease: results from a sample of treated patients in a tertiary-referral memory clinic.
        Int J Geriatr Psychiatry. 2012; 27: 844-853
        • Harris M.
        • Blundell J.
        Audit of necropsies in a British district general hospital.
        J Clin Pathol. 1991; 44: 862-865
        • Lo R.Y.
        • Hubbard A.E.
        • Shaw L.M.
        • et al.
        Longitudinal change of biomarkers in cognitive decline.
        Arch Neurol. 2011; 68: 1257-1266
        • Landau S.
        • Harvey D.
        • Madison C.
        • et al.
        Comparing predictors of conversion and decline in mild cognitive impairment.
        Neurology. 2010; 75: 230-238
        • Jonsson T.
        • Atwal J.K.
        • Steinberg S.
        • et al.
        A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.
        Nature. 2012; 488: 96-99
        • Harold D.
        • Abraham R.
        • Hollingworth P.
        • et al.
        Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.
        Nat Genet. 2009; 41: 1088-1093
        • Naj A.C.
        • Jun G.
        • Beecham G.W.
        • et al.
        Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
        Nat Genet. 2011; 43: 436-441